INTRODUCTION
Obsessive-compulsive disorder (OCD), an anxiety disorder characterized by intrusive unwanted thoughts, ideas, or images that are distressing (obsessions) and urges to perform ritualistic behaviors or mental acts (compulsions) to reduce this distress, does not have a simple etiopathogenesis. Growing evidence has revealed its complex neurobiological basis and has contributed to our understanding of the underlying mechanisms of OCD, which is associated with an important impairment in occupational, academic, and social functioning. The authors have performed a number of investigations on the causes of OCD, starting with free radicals, other neurobiological parameters such as leptin, homocysteine and folate, and neuroimaging, including key brain regions, hippocampus, amygdala, or pituitary gland (1) (2) (3) (4) (5) (6) . Recently, we have examined plasma adiponectin levels in patients with OCD (7) . The plasma adiponectin and glucose concentrations were measured in 23 patients (13 females, 10 males) compared with values from 23 age and sex-matched healthy controls (14 females and 9 males). In this context, we obtained a number of important findings to help us understand the pathophysiology of OCD.
Functional neuroimaging studies have focused on the circuit starting from the prefrontal region and continuing through the basal ganglia, particularly the caudate nucleus and thalamus, and ending in the vicinity of the prefrontal region again (8) . In structural brain investigations, same neuroanatomical structures associated with this circuit have drawn attention. Consequently, in these imaging investigations, some regions have been established as key brain areas including the orbito-frontal cortex (OFC), thalamus, caudate nucleus, and anterior cingulate cortex. We also performed two investigations on key brain regions in OCD. In one of them (4), we found that the patients had increased total white matter, as well as left and right thalamus volumes and decreased left and right OFC volumesand a nearsignificant difference in the left anterior cingulate. In the second investigation, we examined the effect of refractoriness to treatment on volumetric brain data in OCD patients (9) . We found that first applying patients had significantly smaller left and right OFC volumes compared to treatment-responders and healthy controls, with a significant difference between refractory patients and treatment-responders No significant difference was found between the volumes of first applying patients compared to those of refractory patients. Also, we found that the anterior cingulate exhibited a near-significant difference only between first applying patients and healthy controls on the left side. In the same investigation, first applying patients had significantly greater left and right thalamus volumes compared to treatment responders and healthy controls and there was a considerable difference in regard to thalamic volumes between refractory patients and treatment responders, suggesting that reductions in OFC and increase in thalamic volumes might be associated with refractoriness of OCD and not be due to changes in the cingulate and caudate regions. We also evaluated the volumes of the hippocampus and amygdala in patients with refractory OCD and detected that mean left and right hippocampal and amygdala volumes of the patients were smaller than those of the healthy controls, and concluded that hippocampal and amygdalar abnormalities might be involved in refractoriness of OCD. On the other hand, a loss of normal hemispheric asymmetry of the hippocampal-amygdala complex (10) and other amygdala volumetric differences (10,11) have been reported previously. In addition, another candidate neuroanatomical region in the understanding of OCD is the pituitary gland since limbic-hypothalamicpituitary-adrenal (LHPA) axis abnormalities have been reported in patients with OCD. In a pediatric OCD population, MacMaster et al. (12) found that pituitary volumes were significantly smaller when compared to those of healthy control subjects (11% smaller). However, to date, dorsolateral prefrontal cortex (DLPFC) volumes have not been evaluated in OCD. The DLPFC is an important section of the prefrontal cortex, associated with executive function, attention, nonverbal memory, and visuospatial skills which have been reported to be disabled in OCD. For example, some investigations have showed that patients with OCD had impaired measures of executive function (13, 14) , whereas others have demonstrated nonverbal memory deficits (15, 16) . Moreover, Russell et al. (17) examined prefrontal cortex neurochemistry in pediatric patients with OCD and found that a significant increase (21% higher) in n-acetylaspartate (NAA) was observed in the left but not right DLPFC in OCD patients compared to control subjects, without any significant differences in choline (CHO) or creatine (CRE) levels. This investigation suggests a neurochemical alteration in the DLPFC in OCD. However, no volumetric study has evaluated that region; hence, we we conducted the present study, in which we aimed to examine DLPFC volumes in patients with OCD.
MATERIALS AND METHODS

Subjects And Clinical Evaluations
The subjects were comprised of 21 patients (mean age: 30.24; S.D.=5.15) with OCD and 17 normal controls(mean age: 30.06 S.D.=4,28). The two groups did not differ with respect to sex ratio, age or handedness. Demographic characteristics of the patients and healthy normal subjects enrolled in the study are given in Table 1 . The patients with OCD, who were assessed according to the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) and the Structured Clinical Interview for the Diagnostic Schedule for Mental Disorders-Fourth Edition (SCID) (18, 19) , were recruited from the outpatient setting. In this study, we included pure OCD patients, who had no current comorbid mental disorders. Written informed consents were obtained from the study subjects. The procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 1983.
Exclusion criteria were a history of significant head injury, any abnormality on MRI, a history of DSM-IV substance abuse or seizure disorder or a history of psychotic disorder. Exclusion criteria for the normal subjects, who were matched on age, sex, education and handedness were any history of DSM-IV axis I disorders scored with the SCID in self or in a first-degree relative, existence of current medical or neurologic problems or any history of seizure. Of the patients, two had a lifetime major depressive disorder and one had a specific phobia.
Psychopathological evaluation was performed by means of clinical interviews, the Yale Brown Obsession Compulsion Scale (Y-BOCS) for measuring the level of OCD (20) and the Hamilton Depression Rating Scale (HDRS) (21) for evaluation of accompanying depressive symptoms. None of the subjects met the criteria for current any psychiatric disorder.
MRI Procedure
As in our previous MRI investigations, images were obtained on a 1.5-Tesla GE signa Excite high speed scanner (Milwakuee, USA). With the following parameters, an high-resolution structural image of the entire brain was obtained using sagittally acquired 3D spiral fast spin echo high-resolution images: repetition time [TR]=2000 ms, echo time [TE]=15.6 ms, field of view [FOV]=240 mm, flip angle=200, bandwidth=20.8, slice thickness=2.4 mm, echo spacing=15.6 ms, 8 echoes, resolution=0.9375×0.9375×2.4 mm. Spiral pulse sequences were employed because of insensitivity to subject motion. Manual tracings were obtained by the neuroradiologist from our team (HY) who was blind to the patients' diagnoses. By using a computer workstation running the GE Volume Viewer voxtool 3.0 64q software, volumetric measurements were computed. The intra-class correlation coefficients for all anatomical measures were above r=0.90. Measured brain structures consisted of the whole brain, total gray and white matter volumes and the DLPFC. When determining the boundaries of the DLPFC, the investigations performed by Prasad et al. (22) and Volpe et al. (23) were used. In addition, we also benefited from standard brain atlases (24) (25) (26) . The superior limit was determined as the superior frontal sulcus and the superior border of the Sylvian fissure was defined as the inferior limit. The lateral border of the brain itself was accepted as the lateral boundary of the DLPFC. The posterior boundary was defined as the most posterior coronal slice when the genu of the corpus callosum appeared. The point linking the most medial point of the superior frontal sulcus to the horizontal branch of the Sylvian fissure was defined as the medial border.
Statistical Analysis
The SPSS for Windows software, version 13.0 (SPSS, Chicago, IL) was used to perform analysis of covariance (ANCOVA), t test and partial correlation analyses. The general linear model ANCOVA was performed with diagnostic group as the class variable, with age and total brain volume (TBV) as covariates, in order to compare DLPFC measurements between patients and controls. Correlation analyses were done by using Spearman's rank test. Statistical significance was defined as P<0.05 by a two-tailed test.
RESULTS
Comparisons of the DLPFC volumes of the OCD patients and those of healthy comparison subjects are shown in Figure 1 
DISCUSSION
This study suggests that the DLPFC volumes seemed to be similar in patients with OCD compared to those of healthy controls. Thus, DLPFC does not appear to structurally contribute to the deficits in executive function, attention, nonverbal memory, and visuospatial skills which have been reported in OCD. The present study provides important new data about the DLPFC structure in OCD without the confounding effects of psychoactive medications and without potential influence of illness progression. In addition, the existence of depressive symptoms, as assessed by the HDRS, did not seem to impact our findings, because there was no correlation between scores and DLPFC size. This is the first study investigating regional morphology of the DLPFC in OCD patients. However, there have been limited studies investigating functional and neurochemical parameters of the DLPFC in OCD. Among these, Russell et al. (17) measured NAA (a putative neuronal marker), CHO and CRE in the right and left DLPFC of 15 treatment-naive OCD patients, 8-15 years of age, and 15 case-matched healthy controls. They found that the OCD patients had significantly increased NAA values in the left but not right DLPFC compared to healthy controls, without any differences on CHO or CRE levels. The DLPFC is an important prefrontal cortex section, associated with executive function, attention, nonverbal memory, and visuospatial skills, which have been reported to have disabled in OCD. It has been demonstrated that patients with OCD had impaired measures of executive function (13, 14) whereas the other studies such as Christensen et al. (15) and Dirson et al. (16) demonstrated nonverbal memory deficits. As can be seen in these reports, functions associated with the DLPFC seemed to be affected in OCD patients. A unique study evaluating neurochemicals in OCD patients may account for these function disabilities in patients with OCD (17) . On the other hand, our investigation found that DLPFC volumes remained unchanged in the patients with OCD and therefore there might not be an underlying structural basis for the neurochemical changes and executive function disorders in OCD that have been reported by others.
Our investigation has some limitations and thus, the conclusions have to be considered with caution. First of all, our experimental sample was small, with large standard deviations. Other limitations were the lack of consideration of the severity of the OCD symptoms, treatment effects, gender differences, and IQ effects.
Finally based on our finding that DLPFC volumes remained unchanged in patients with OCD, , despite some limitation factors, the present study suggests that there might not be an underlying structural basis for neurochemical changes in the DLPFC as well as executive function disorders in OCDFuture studies are required to investigate the effects of pharmacotherapy on the structure and neurochemicallevels of the DLPFC in larger samples.
